Tartu University Genome Foundation launched a successful Horizon 2020 Twinning project (ePerMed) to facilitate the development of personalized medicine in Europe.

Invent Baltics team helped Tartu University Genome Foundation to coordinate the project proposal preparation to the Horizon 2020 Twinning measure. The proposal got maximum points in the evaluation and was awarded a Twinning grant. 


ePerMed project is aimed at increasing the scientific excellence of EGC-UT in the fields of functional and statistical genomics of common and rare diseases by capitalizing on knowledge transfer from two internationally together with renowned partners in the field of human and medical genomics – UNIL-CIG in Switzerland and UH-FIMM in Finland.

As a foreseen result of the ePerMed project, EGC-UT will have the capacity to move from the current research on the genome-wide association studies to advanced research of disease mechanisms and to clinical benefits through early diagnosis, reliable risk stratification and improved treatment strategies. Ultimately, this will enable EGC-UT to deliver effective personalized medicine across several clinically relevant phenotypic traits and diseases.

The main goal of Horizon 2020 “Twinning” measure is to strengthen the overall scientific and innovation capacity of universities and research centers through research partnerships and knowledge transfer. The next call for Twinning proposals is in the second half of 2017. For more information and initial consultancy, please contact:

Silver Toomla

silver.toomla@invent.ee

+372 51 71 781